Amiodarone, an iodinated benzofuran derivative and class III antiarrhythmic, is widely used in the treatment and prevention of ventricular and supraventricular tachyarrhythmias. Although it has been widely used since 1969, amiodarone pulmonary toxicity (APT) was first described in 1980. I A small number of cases of acute postoperative respiratory failure attributable to APT have been described. 24 This report details a case of life-threatening APT which occurred immediately after placement of an Automatic Implantable Cardioverter/Defibrillator (AI CD) under general anaesthesia.
CASE REPORT
A 61-year-old man with a two-year history of syncope due to ventricular tachycardia was scheduled to undergo AI CD placement under general anaesthesia. He had significant coronary artery disease and had suffered myocardial infarctions ten and eighteen years previously. Two years prior to admission, cardiac catheterisation and angiography revealed proximal occlusion of his right coronary artery, moderate left ventricular dysfunction and a small inferior wall aneurysm. Despite this, and a 30-pack/year history of cigarette smoking (he had stopped smoking three years previously), his pre-admission exercise tolerance was good and no symptoms or signs of respiratory disease were elicited. A chest X-ray revealed mild perihilar pulmonary congestion.
Two years previously, amiodarone 600 mg daily had been commenced, and after six months this dose was reduced to 400 mg daily when he complained of increasing fatigue and dyspnoea. Resolution of these symptoms followed this dose reduction.
A temporary pacing wire was placed preoperatively through the left subclavian vein. 250 mcg and maintained with nitrous oxide, enflurane and increments of fentanyl and papaveretum. Fi02 was 0.32 for most of the case but briefly increased to 1.0 when the Sp02 decreased to 96070. The pericardium was opened through an upper abdominal incision and two standard patches were placed on the anterior and inferior surfaces of the right and left ventricles. Immediately following extubation, the patient was noted to be tachypnoeic (45 bpm) and febrile (38.8 QC). Fine crackles were audible throughout both lungfields. With the patient breathing 100070 oxygen through a closed anaesthetic circuit, arterial blood gas analysis revealed a Pa02 of 60 mmHg. Central venous pressure had not changed from the preoperative)evel (10-11 cm H20). On chest X-ray, diffuse bilateral pulmonary infiltrates were noted. Transthoracic echocardiography demonstrated no evidence of cardiac tamponade.
A provisional diagnosis of pulmonary oedema secondary to left ventricular failure was made. The patient was transferred to the Intensive Care Unit (lCU) where frusemide (initial dose 40 mg and six subsequent doses of 20 mg intravenously during the ensuing three days) and captopril (0.625 mg orally) were administered and fluids restricted. Oxygen therapy using a CPAP mask (7.5 cm H20) and Fi02 = 0.60 were required to maintain Sp02 > 90070. Over the subsequent three days, this regimen produced no clinical improvement and endotracheal intubation and intermittent positive pressure ventilation were required to maintain adequate oxygenation. A pulmonary artery catheter was inserted on the fourth postoperative day, revealing a pulmonary artery wedge pressure of 10 mmHg. Diuretic therapy was therefore discontinued.
At this time APT was considered a possible diagnosis and amiodarone, which had been continued postoperatively, was discontinued and methylprednisolone (125 mg six-hourly for six days and tapered thereafter) was commenced. Examination of a specimen obtained at open lung biopsy revealed a low-grade pneumonitis and lipid-containing histiocytes. On electron microscopy, intracellular myelin bodies showing the tightly packed lamellae consistent with, but not pathognomic of, APT were seen. s Gradual improvement in pulmonary gas exchange occurred over the subsequent four days, at which time the patient was successfully extubated. Chest X-ray appearances improved slowly over the following weeks. When he was discharged from hospital four weeks postoperatively, his respiratory function had almost returned to its pre-admission level.
DISCUSSION
This case report demonstrates that postoperative respiratory failure due to APT may occur in patients taking amiodarone, even if preoperative respiratory function is adequate. Anaesthetists undertaking care of such patients should be aware of this potential complication.
APT occurs in approximately 5 to 71Jfo of patients receiving long-term treatment with amiodarone. 5 The pathogenesis of APT is uncertain but may be a doserelated (> 400 mg/day) toxic effect or may be immunologically mediated, involving both humoral and cellular responses. 5.6 Identification of patients at increased risk of developing APT is difficult. Neither indices of lung mechanics nor carbon monoxide diffusion capacity 7 are useful predictors of APT.
Clinical history and the chest X-ray are most useful in detecting serious toxicity. Clinical presentation may either be insidious (non-productive cough, dyspnoea, weight loss, occasionally fever) or acute in onset. 5 Since many of the patients have an underlying cardiomyopathy or coronary artery disease, an acute presentation of APT may be mistaken for congestive cardiac failure (as occurred in the case described). Chest Xray appearances of APT are variable. Patchy acinar infiltrates located peripherally, especially in the upper lobes, are suggestive of APT. <.9 Elevation in WCC (non-specific differential), ESR and LDH may occur but are non-specific. Pulmonary function tests demonstrate a restrictive pattern and arterial blood gas analysis shows a variable degree of hypoxaemia. The diagnostic usefulness of gallium 67 lung scanning and broncho-alveolar lavage (T-suppressorlcytotoxic lymphocytosis) is unproven. 10 Treatment usually comprises discontinuation of amiodarone, supportive measures and a short course of corticosteroids. The mortality associated with APT is approximately 251Jfo. 10 Tuzcu et al 4 demonstrated that early postoperative respiratory failure occurred more commonly in patients who were on amiodarone prior to cardiac surgery than in patients who only received amiodarone after cardiac surgery. Life-threatening respiratory failure due to APT may also occur following non-cardiac surgery. 2 The mechanism of acute postoperative APT is uncertain. It is likely that subclinical toxicity exists preoperatively and is exacerbated by perioperative fctors such as oxygen toxicity or congestive cardiac failure. The anaesthetic management of such patients should include careful fluid management and avoidance of unnecessarily high Fi02.
